You are here

Roche to pay more than US$1b for majority stake in tumour-testing company

156481133.jpg
The Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority of the tumour-testing company Foundation Medicine for more than US$1 billion, in a deal aimed at improving both cancer treatment and drug development.

New York

THE Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority of the tumour-testing company Foundation Medicine for more than US$1 billion, in a deal aimed at improving both cancer treatment and drug development.

Foundation is the leader in the

sentifi.com

Market voices on:

Powered by GET.comGetCom